HGWM
FOLD

Harvest Group Wealth Management’s Amicus Therapeutics FOLD Stock Holding History

Harvest Group Wealth Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$1.73K Hold
156
– – ﹤0.01% 130
2022
Q4 		$1.91K Buy
156
+16
+11% +$180 ﹤0.01% 119
2022
Q3 		$2K Buy
140
+5
+4% +$56 ﹤0.01% 115
2022
Q2 		$1K Buy
135
+75
+125% +$618 ﹤0.01% 153
2022
Q1 		$1K Buy
+60
New +$563 ﹤0.01% 115

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Harvest Group Wealth Management's FOLD Position: Q1 2023 in Review

Harvest Group Wealth Management held its Amicus Therapeutics (FOLD) position steady in Q1 2023 at 156 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #130.

Harvest Group Wealth Management first reported a position in FOLD in Q1 2022 and has held it in 5 quarters since. The position peaked at $2K in Q3 2022. 226 funds tracked by Wall St. Rank hold FOLD as of Q1 2023.

  • Harvest Group Wealth Management held 156 shares of Amicus Therapeutics worth $1.73K as of Q1 2023.
  • Harvest Group Wealth Management left its Amicus Therapeutics share count unchanged in Q1 2023.
  • Amicus Therapeutics made up ﹤0.01% of Harvest Group Wealth Management's portfolio in Q1 2023, its #130 holding.
  • Harvest Group Wealth Management first reported a position in Amicus Therapeutics in Q1 2022 and has held it in 5 quarters since.
  • Harvest Group Wealth Management's Amicus Therapeutics position peaked at $2K in Q3 2022.
  • 226 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2023.

Based on Harvest Group Wealth Management's 13F filing for Q1 2023, filed 28 Apr 2023.